OQS
BVS icon

Occudo Quantitative Strategies’s Bioventus BVS Stock Holding History

Occudo Quantitative Strategies’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,933
Closed -$67.3K – 762
2024
Q1 		$67.3K Sell
12,933
-10,195
-44% -$49.8K 0.01% 679
2023
Q4 		$122K Buy
+23,128
New +$91.5K 0.02% 695
2023
Q2 		– Sell
-10,739
Closed -$11.5K – 1035
2023
Q1 		$11.5K Sell
10,739
-39,022
-78% -$74.6K ﹤0.01% 872
2022
Q4 		$130K Buy
+49,761
New +$217K 0.02% 829
2022
Q2 		– Sell
-11,357
Closed -$160K – 1148
2022
Q1 		$160K Sell
11,357
-2,913
-20% -$39K 0.01% 978
2021
Q4 		$207K Sell
14,270
-1,087
-7% -$15.5K 0.02% 883
2021
Q3 		$217K Buy
+15,357
New +$236K 0.03% 837

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Occudo Quantitative Strategies's BVS Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of Bioventus (BVS) in Q2 2024, closing a stake of 12,933 shares — an estimated $67.3K sold.

Occudo Quantitative Strategies first reported a position in BVS in Q3 2021 and held it in 7 quarters. The position peaked at $217K in Q3 2021. 103 funds tracked by Wall St. Rank hold BVS as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining Bioventus position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 12,933 Bioventus shares in Q2 2024, an estimated $67.3K.
  • Occudo Quantitative Strategies first reported a position in Bioventus in Q3 2021 and held it in 7 quarters.
  • Occudo Quantitative Strategies's Bioventus position peaked at $217K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Bioventus as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.